Welcome to our dedicated page for Ventas news (Ticker: VTR), a resource for investors and traders seeking the latest updates and insights on Ventas stock.
Ventas, Inc. is an S&P 500 real estate investment trust with a healthcare and senior housing property portfolio in North America and the United Kingdom. News about VTR commonly covers quarterly results, senior housing operating portfolio performance, occupancy and RevPOR trends, net operating income, healthcare real estate investments, dividends and tax treatment of distributions.
Company updates also address investor presentations, earnings calls, capital allocation and portfolio categories that include senior housing communities, outpatient medical buildings, research centers and healthcare facilities.
Summary not available.
Ventas, Inc. announced the pricing of a private offering in Canada, totaling Cdn$600 million of 5.398% Senior Notes, Series I due 2028. The offering is set to close on April 21, 2023. The Notes will be issued by the Company's wholly-owned subsidiary, Ventas Canada Finance Limited, and are unconditionally guaranteed by Ventas. Proceeds will fund tender offers to purchase existing Senior Notes due in 2024, totaling up to Cdn$500 million, with any remaining funds allocated for working capital. The Notes will mature on April 21, 2028, with interest payable semi-annually.
Ventas (NYSE: VTR) has initiated a private offering in Canada for Cdn$500 million of Senior Notes due 2028. The Notes will be issued by Ventas Canada Finance Limited, targeting accredited investors on a prospectus-exempt basis. Proceeds will fund tender offers for the company's existing Senior Notes, with any remaining funds allocated for general corporate purposes. The offering is contingent upon final pricing and satisfaction of conditions outlined in the purchase offer. These Notes will not be registered under U.S. securities laws and cannot be sold in the U.S. without registration or exemption.
Ventas, Inc. (NYSE: VTR) has initiated cash tender offers to acquire outstanding notes totaling up to Cdn$500 million from its subsidiary, Ventas Canada Finance Limited. The notes include 2.80% Senior Notes, Series E due April 2024 and 4.125% Senior Notes, Series B due September 2024. Valid tenders must be submitted by 5:00 p.m. Toronto time on May 1, 2023, with an early tender option available until April 19, 2023. The Offers are subject to conditions detailed in the Offer to Purchase.
Ventas, Inc. (NYSE: VTR) has announced its intention to take ownership of the collateral supporting its $486 million Santerre Mezzanine Loan, secured by a diverse portfolio of healthcare-related properties. The ownership will be acquired through a 'loan to own' structure, aligning with Ventas's 2023 financial guidance. This Santerre Portfolio includes 88 medical office buildings, 16 senior housing communities, and 48 skilled nursing facilities. The company anticipates completing this process in Q2 2023 while also managing a $1 billion non-recourse senior loan associated with these assets.
Ventas, Inc. (NYSE: VTR) announced a quarterly dividend of $0.45 per common share, payable on April 13, 2023. Stockholders of record as of April 3, 2023, will receive the dividend in cash. Ventas operates over 1,200 properties across the U.S., Canada, and the U.K., focusing on healthcare and real estate, driven by the growing aging population. With a strong portfolio and a successful long-term strategy, Ventas aims for reliable growth and industry-leading ESG achievements.
Ventas, Inc. (NYSE: VTR) will present at the Citi 2023 Global Property CEO Conference on March 7, 2023, at 3:00 p.m. Eastern Time. The presentation can be accessed via a webcast on the company’s website at ir.ventasreit.com/events-and-presentations.
Accompanying materials for the presentation will be available on or around March 6, 2023. Ventas operates over 1,200 properties across the U.S., Canada, and the U.K., focusing on healthcare and real estate sectors. The company follows a diversified strategy to enhance the value of senior living and healthcare facilities.
Ventas, Inc. (NYSE: VTR) reported its fourth quarter and full year 2022 results, highlighting a net loss of ($0.11) per share and a year-over-year NOI growth of 7.5%. Normalized Funds from Operations (FFO) per share remained stable at $0.73. The company saw a significant 19.1% growth in same-store cash NOI driven by strong performance in its SHOP portfolio. Notably, Ventas earned its first promote revenue approximating $0.02 per share from its third-party investment management business. The company committed $1.2 billion in investments throughout 2022, with substantial projects emphasizing life sciences and senior housing. Finally, Ventas has a robust liquidity position with $2.4 billion available for future investments.
Ventas, Inc. (NYSE: VTR) has appointed J. Justin Hutchens as Chief Investment Officer while retaining his role as Executive Vice President of Senior Housing. This dual role aims to enhance capital allocation and streamline management, with Hutchens overseeing both Senior Housing and Investments teams. Hutchens, with over 25 years of experience, has successfully led Ventas’s Senior Housing business since 2020, managing nearly half of the company's portfolio. He succeeds John D. Cobb, who will transition to a strategic advisor role. This management change is viewed as a strategic move to bolster operational and investment strategies.
Ventas, Inc. (NYSE: VTR) will release its Q4 2022 earnings on February 9, 2023, after NYSE trading closes. A conference call for discussing these results is scheduled for February 10, 2023, at 10:00 a.m. ET. Interested parties can join via dial-in at (888) 330-3576 or +1 (646) 960-0672 for international access. The webcast will be available on the company's Investor Relations page. Ventas, a leading real estate investment trust, maintains a diversified portfolio exceeding 1,200 properties across the U.S., Canada, and the U.K., focusing on healthcare-related real estate.